The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How ...

In the 2024 fiscal year, which ended June 30, innovators disclosed 372 new technologies, licensed 121, and started nine ...

Issuer: CureVac / Key word (s): Conference CureVac to Present at the 12th International mRNA Health Conference 04.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this ...

The science behind vaccines is based on the fundamental principle of training the immune system to recognize and fight ...

If the influenza virus infecting cattle workers starts a pandemic, help in the form of a vaccine is months away ...

Policy, funding, and public apathy hold back the search for more advanced COVID vaccines — but researchers persist and have ...

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 4, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based ...

A long-standing goal of neuroscience is to understand how molecules and cellular structures on a microscale give rise to communication between brain regions at the macroscale.

Anyone with COVID-19 during the summer has some, but not full, protection against germs spreading in fall and winter.

The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and ...

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer Experienced CFO and investment banker with 30-year track record will ...

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / October 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global ...